Shunqiang Li, PhD

Shunqiang Li, PhD

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, Washington University School of Medicine

Research Interest

1) Establishment and characterization of patient-derived xenograft (PDX) models, 2) PDX-based preclinical testing of new anticancer drugs and treatments, 3) Application of PDX models to cancer translation research, including tumorigenesis, resistance, metastasis, and biomarker, 4) HAMLET core service


  • 1999: PhD, pharmacology, Chinese Academy of Medical Sciences and Peking Union Medical College, P.R. China


  • 1999 - 2002: Postdoctoral research, Fred Hutchinson Cancer Research Center, Seattle
  • 2002 - 2004: Postdoctoral research, University of North Carolina at Chapel Hill

Selected Research Publications

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
  • Anurag M, Jaehnig EJ, Krug K, [...] Li S, [...] Ellis MJ
  • Cancer Discov 2022
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer.
  • Punturi NB, Seker S, Devarakonda V, [...] Li S, [...] Haricharan S
  • Nat Commun 2021
Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.
  • Wang X, Veeraraghavan J, Liu CC, [...] Li S, [...] Wang XS
  • Clin Cancer Res 2021
Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use.
  • Karakoçak BB, Laradji A, Primeau T, [...] Li S, Ravi N
  • ACS Appl Mater Interfaces 2021
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
  • Woo XY, Giordano J, Srivastava A, [...] Li S, [...] Chuang JH
  • Nat Genet 2021

View All Publications

Contact Information

Contact Information